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Abstract 8 
Bacillus thuringiensis crystal (Cry) proteins, used for decades as insecticidal toxins, are well known to be toxic 9 
to certain insects, but not to mammals. A novel group of Cry toxins called parasporins possess a strong cytocidal 10 
activity against some human cancer cells. Cry41Aa, or parasporin3, closely resembles commercially used 11 
insecticidal toxins and yet is toxic to the human hepatic cancer cell line HepG2, disrupting membranes of 12 
susceptible cells, similar to its insecticidal counterparts. In this study, we explore the protective effect that the 13 
common divalent metal chelator EGTA exerts on Cry41Aa’s activity on HepG2 cells. Our results indicate that 14 
rather than interfering with a signalling pathway as a result of chelating cations in the medium, the chelator 15 
prevented the toxin’s interaction with the membrane, and thus the subsequent steps of membrane damage and 16 
p38 phosphorylation, by removing cations bound to plasma membrane components. BAPTA and DTPA also 17 
inhibited Cry41Aa toxicity but at higher concentrations. We also show for the first time that Cry41Aa induces 18 
pore formation in planar lipid bilayers. This activity is not altered by EGTA, consistent with a biological context 19 
of chelation. Salt supplementation assays identified Ca2+, Mn2+ and Zn2+ as being able to reinstate Cry41Aa 20 
activity. Our data suggest the existence of one or more metal cation-dependent receptors in the Cry41Aa 21 
mechanism of action. 22 
Keywords: EGTA · Parasporin ·  Pore-forming toxin ·  HepG2 ·  Cry toxin ·  Planar lipid bilayers ·  Patch-23 
clamping 24 
Abbreviations: EGTA, ethylene glycol-bis(β-aminoethyl ether)-N,N,N',N'-tetraacetic acid; EDTA, 2, 2', 2'', 2''' - 25 
(Ethane-1, 2-diyldinitrilo) tetraacetic acid; BAPTA, 1,2-bis(o-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid; 26 
DTPA, 2-[Bis[2-[bis(carboxymethyl)amino]ethyl]amino]acetic acid; BBMV, brush border membrane 27 
vesicles;POPC, 1palmitoyl-2-oleoyl-sn-glycero-3phosphocholine; POPE, 1-palmitoyl-2oleoyl-sn-glycero-3-28 
phosphoethanolamine. 29 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
2 
 
1. Introduction 30 
Bacillus thuringiensis (Bt) is an entomopathogenic bacterium that, among other virulence factors, produces 31 
parasporal crystal (Cry) proteins used commercially as insecticides in sprays and expressed in transgenic crops 32 
(1). After solubilisation and proteolytic activation in the insect gut, they bind to specific receptors and kill cells 33 
via pore formation; although other modes of action have been proposed (2). A small group of Cry toxins known 34 
as parasporins (PS) presents activity against some human cancer cell lines and their application in anti-cancer 35 
therapy was suggested (3). Classified into six families PS1-6 (4), they seem to act via different mechanisms, 36 
including pore formation (5) and apoptosis (6). Parasporin3 or Cry41Aa is highly selective against human 37 
hepatic (HepG2) and myeloid leukaemia (HL-60) cancer cells, while being structurally similar to some 38 
commercially used insecticidal Cry toxins (7). We investigated its mode of action and the results are consistent 39 
with Cry41Aa being a pore-forming toxin (PFT). The toxin induced extensive membrane damage, cell swelling, 40 
rapid decrease in ATP levels and metabolic activity, but no activation of caspases or oxidative stress (8). 41 
However, confirmation of specific toxin binding to the plasma membrane was unsuccessful and despite rapid 42 
loss of membrane integrity, the nature of permeabilization has never been closely investigated. Here we 43 
demonstrate that Cry41Aa formed stable channels in planar lipid bilayers and induced large whole-cell currents 44 
in HepG2 cells. Interestingly, we have noticed an inhibitory effect of EGTA on Cry41Aa activity. EGTA, like 45 
EDTA, is a non-specific chelator of metal ions commonly used to test the roles of extracellular cations in the 46 
activities of various proteins including Cry toxins. It was shown that EDTA decreased pore formation by 47 
Cry1Aa, Cry1Ac and Cry1Ea in isolated insect BBMV and the role of cations in Cry toxin binding and pore 48 
formation was suggested (9). Extracellular Ca2+ was shown to be indispensable for the activity of PS1 49 
(Cry31Aa1) in mediating apoptosis in HeLa cells (6). Extra– and intracellular increases in Ca2+ augmented 50 
Cry1C toxicity in Spodoptera frugiperda Sf9 cells, possibly via a Ca2+-dependent intracellular pathway (10). 51 
Toxicity of Bt var. entomocidus against Spodoptera littoralis was enhanced by Ca2+ and Zn2+ salts (11). 52 
However, osmotic swelling assays using Manduca sexta BBMV and Cry1 toxins showed some contradictory 53 
results; for example, Ca2+ increased the rate of pore formation by Cry1Ac, but reduced pore formation by 54 
Cry1Ca (12). Moreover, there are reports of synergistic effects of EDTA and Cry toxin-containing Dipel in 55 
resistant Plutella xylostella larvae (13). Despite a vast amount of literature on the subject, few researchers have 56 
addressed the problem of non-target cation binding and tend to focus primarily on a single metal-chelator 57 
complex. In this study, the chelator effect is investigated on the activity of Cry41Aa in HepG2 cells, taking into 58 
consideration the fact that EGTA forms complexes with a broad number of metal cations, existing both in free- 59 
and protein-bound forms. 60 
2. Materials and methods 61 
2.1. Toxin harvesting and purification 62 
Recombinant Bt strains were grown for 3 days at 30°C on Luria-Bertani plates with 5 µg/ml chloramphenicol. 63 
Cells containing crystals were sonicated in water, washed twice in 0.3 M NaCl, and the pellets were re-64 
suspended in water. The protoxin-spore mixture was solubilized at 37°C for 1 h in 50 mM Na2CO3 buffer, pH 65 
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10.5 and containing 5 mM DTT. The supernatant was incubated with trypsin (Sigma, UK) for 1h at 37°C in a 66 
ratio of 1 mg enzyme per 1 mg protoxin. After activation a protease inhibitor (Roche complete mini EDTA-free, 67 
Sigma) was added and the toxin was purified on a 15 ml Sephacryl S-200 High Resolution (Amersham 68 
Bioscience) gel filtration column. Fractions were eluted in 25 mM Tris/150 mM NaCl (pH 7.4) and protein 69 
concentration was determined by a Bradford assay (Protein Assay Kit, Bio-Rad, UK) using BSA as the standard. 70 
2.2. Cell culture 71 
The HepG2 cell line was purchased from the European Collection of Cell Cultures (ECCAC, Salisbury, UK). 72 
Cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM), high glucose, supplemented with 73 
10% fetal calf serum (FCS), 100 U/mL penicillin, 100 µg/mL streptomycin, 292 µg/mL L-glutamine (referred 74 
here as complete DMEM) in 75cm2 flasks at 37°C in a humidified 5% CO2 incubator. When the cells reached 75 
70-80% confluency, they were split using 0.05% trypsin-EDTA. 76 
2.3. Cell assays 77 
Unless specified otherwise, 90 µl of cell suspension containing approximately 22,500 HepG2 cells were 78 
dispensed in triplicate into a 96-well plate in complete DMEM and 20 h later each well received appropriate 79 
treatment. Data are mean values ± S.E.M. of triplicate wells, performed in duplicate experiments. Cell viability 80 
was assessed using the CellTiter-Blue assay (Promega, UK) as an endpoint method with a 2-hour incubation 81 
with the reagent. Membrane integrity was determined with the CellTox Green cytotoxicity assay (Promega, UK) 82 
using ‘Express, No-Step Addition at Seeding Method’ according to the manufacturer’s instructions. 83 
2.4. Experiments with chelators 84 
EDTA and CaCl2 were purchased from AnalaR BDH (Poole, Dorset, UK); MgCl2, Dulbecco's phosphate-85 
buffered saline (DPBS)
 
and cell culture media from ThermoFisher Scientific (UK); EGTA, BAPTA, DTPA 86 
from Trocis Bioscience (Abingdon, UK). Other reagents were purchased from Sigma Aldrich (UK). EGTA and 87 
EDTA were prepared as a 55 mM stock solution in distilled water (pH adjusted to 8), later diluted in culture 88 
medium accordingly. BAPTA and DTPA were prepared according to the manufacturer's guidelines. Mock cells 89 
were treated with the equal amount of distilled water only. Initially, cells were pre-treated with 5 mM EGTA 30 90 
min prior to toxin treatment. Later, in light of further results, the dose and time were reduced to 2 mM and 10 91 
min. Periods of cell culture in DPBS without calcium and magnesium, Advanced DMEM (medium allowing 92 
cell growth with reduced FCS supplementation) and Ca2+-free DMEM (high glucose, no calcium) were kept to a 93 
minimum. Experiments that involved Ca2+-free medium were carried out straight after cell seeding, as lack of 94 
extracellular Ca2+ led to a detrimental fall in viability after 20 h. For statistical comparison of treatments in salt 95 
supplementation experiments, Post-Hoc analysis applying a Bonferroni adjustment was carried out using IBM 96 
SPSS Statistics for Windows, version 22.0. (IBM Corp, Armonk, NY, USA). Dose-response curves were 97 
generated using nonlinear regression analysis and the equation ‘Dose-response – Stimulation, [Agonist] vs. 98 
response - Variable slope’ in GraphPad Prism version 8.1.0 (GraphPad Software, La Jolla, CA, USA, 99 
www.graphpad.com). Calculations of bound and free Ca2+, Mg2+ and EGTA were performed using the 100 
Ca/Mg/ATP/EGTA calculator version 1, available online: maxchelator.stanford.edu/. 101 
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2.5. Western blot analysis 102 
HepG2 cells were seeded at the density of 25 x 104 cells/ml in 6-well plates in complete DMEM. After ~70% 103 
confluency was achieved, cells were pre-treated with 2 mM EGTA or water for 10 min. Next, sodium arsenite 104 
(0.5 mM), Cry41Aa (15 µg/ml) or buffer were added. 15 minutes after toxin treatment, cells were washed twice 105 
with DPBS at 4°C, gently scraped, spun at low speed (200 x g) and the pellet was lysed at 4°C for 20 min in 106 
Tergitol-type NP-40 buffer (150 mM NaCl, 1% NP-40, 50 mM tris, pH 8.0, 2 mM NaVO4, 1 µM microcystin, 1 107 
mM EDTA, 1 mM EGTA with Roche complete mini EDTA-free protease inhibitors). Precleared lysates (20 min 108 
at 16,873 x g) were subjected to SDS-PAGE and western blot analysis. Proteins were transferred to a 109 
nitrocellulose membrane (Bio-Rad) using a Bio-Rad Trans-Blot Semi-Dry Transfer Cell system (100 mA for 60 110 
min). Probing was done overnight at 4°C in blocking solution containing 3% BSA and primary antibody against 111 
phospho-p38 (ThermoFisher Scientific, MA5 15182, 1:1000) or CD59 (Abcam, ab126777, 1:50000). The next 112 
day membranes were incubated with secondary HRP-conjugated antibody (Abcam, ab97051) and blots 113 
developed on X-ray film (FUJI medical X-ray film).  114 
2.6. Whole-cell patch-clamp electrophysiology experiments 115 
HepG2 cells were seeded at 5 x 104 cells/ml on 24 mm circular glass coverslips 24 – 48 h before experiments. 116 
Cells were washed three times with the bath solution (140 mM NaCl, 5 mM KCl, 1.1 mM MgCl2, 1.1 mM 117 
CaCl2, 10 mM HEPES, pH 7.4) and mounted inside a coverslip holder fitted to the microscope stage (IMT-2, 118 
Olympus). 1 ml of the bath solution was added. Soda lime pipettes (Kimble Chase) were filled with the pipette 119 
solution (140 mM KCl, 1.1 mM MgCl2, 0.1 mM EGTA, 10 mM HEPES, pH 7.4) and had a resistance of around 120 
4 MΩ. The resistance of the seals was in the range of 2-10 GΩ. A −20 mV holding potential and trains of 17 121 
command voltage steps (1-s duration, ranging from −20 to 140 mV, in increments of 10 mV) were applied 122 
before and 20 min after the addition of Cry41Aa (12 µg/ml) to the bath in the presence or absence of 2 mM 123 
EGTA (added 10 min before the toxin). The command voltages were generated by, and the whole-cell currents 124 
were recorded and processed with Axon Digidata 1550 converter (Molecular Devices) and Axopatch – 1D 125 
patch-clamp amplifier (Molecular Devices). Currents were filtered at 10 kHz and sampled at 50 kHz. Data 126 
collection and analysis were conducted using the pCLAMP 10.6 software (Molecular Devices). Error bars 127 
indicate the standard error of the mean. The current – voltage (I/V) curves show the mean currents from three 128 
representative experiments on three different patched cells. Conductance levels were calculated from the slope 129 
of linear regression line of each I/V curve at 20 min. Experiments were performed at room temperature. 130 
2.7. Planar lipid bilayer experiments 131 
Planar lipid bilayer experiments were performed using the methods described previously (14). A lipid mixture 132 
of POPE:POPC:cholesterol  (Avanti Polar Lipids, Alabaster, USA) was prepared in a ratio of 7:2:1 (w/w/w). 133 
Lipids were dried with N2 and then dissolved in n-decane at 20 mg/ml. 1 ml of KCl buffer (150 mM KCl, 1 mM 134 
CaCl2, 10 mM HEPES, pH 7.5) was added to cis and trans – custom made disposable chambers, equipped with 135 
magnetic stirrers. A lipid membrane was painted in a 250 µm diameter hole present at the junction of both 136 
chambers with the lipid mixture using a blunt end glass pipette. Chambers were connected to Ag/AgCl 137 
electrodes through conducting agar bridges (2 M KCl, 1 mM EGTA and 2% agar) and placed inside a small 138 
Faraday enclosure. Voltage was applied to the cis chamber (trans chamber was grounded). Membrane activity 139 
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was recorded for 30 min with holding voltages ranging from -150 to +150 mV to ensure no contamination. 140 
Capacitance of the membrane was 180 - 200 pF. Cry41Aa was added to the cis chamber at 8 µg/ml and current 141 
was recorded at different voltages. All experiments were performed three times, at room temperature. Currents 142 
were acquired using Axopatch-1D patch-clamp amplifier (Molecular Devices, Sunnyvale, USA). Currents were 143 
filtered at 5 kHz and digitized at 50 kHz with Axon Digidata 1440A (Molecular Devices). Recordings were 144 
analysed using pCLAMP 10.5 (Molecular Devices). To measure the conductance, 20-25 current jumps were 145 
recorded for each voltage, grouped and averaged. I/V curves were plotted from the data points fitted by linear 146 
regression. Mean conductance was read from the slope of each I/V curve regression line. At the end of each 147 
experiment, concentration of KCl in the cis chamber was increased to 450 mM, using 3 M KCl, 1 mM CaCl2, 10 148 
mM HEPES, pH 7.5, to measure reversal potential. PK+/PCl- permeability ratios were calculated from the 149 
reversal potential using the Goldman-Hodgkin-Katz equation (15). 150 
3. Results 151 
3.1. Effects of chelation on cells and Cry41Aa toxicity  152 
EGTA is thought to be membrane impermeant and not metabolised by living organisms. Ca2+, one of the most 153 
abundant divalent metal ions present in extracellular fluid and in DMEM cell culture formulation (Table 1), 154 
plays a crucial role in cell physiology (16). It has been shown that removal of extracellular Ca2+ reversibly 155 
increases permeability of tight junctions, leading to cell contraction and reduction of cell-to-cell adhesion (17). 156 
Mouse myoblast C2C12 cells treated with 1.75 mM EGTA for 24 hours showed significant alteration in 157 
morphology resulting from changes in number and distribution of stress fibres and microtubules (18). 24-hour 158 
HepG2 cell exposure to 2 mM EGTA resulted in ~20% reduction of viability (data not shown). For this reason, 159 
all chelator experiments were carried out over a period of up to 6 hours, a time during which no loss of viability 160 
or change in cell morphology were noticed (data not shown). HepG2 cells were preincubated with either EGTA 161 
or EDTA, followed by toxin administration and viability examination (Fig. 1A). Both EDTA and EGTA 162 
significantly reduced the cytotoxicity of Cry41Aa. Cell swelling, a general feature of Cry toxin action (19), was 163 
not observed in the chelators’ presence. EGTA also prevented phosphorylation of p38 MAP kinase in Cry41Aa-164 
treated cells (Fig. 1B). This signalling pathway, commonly triggered by pore formation (20), was induced by 165 
Cry41Aa in the chelator’s absence at 15 min after toxin exposure. The signal matched that of sodium arsenite, a 166 
potent p38 inducer. 167 
3.2. Analysis of possible indirect effects of EGTA 168 
Extensive measures were taken to ensure that EGTA action resulted from metal ion chelation and no other 169 
indirect effect. To test if EGTA was causing the toxin to degrade or precipitate, Cry41Aa was incubated with 170 
EGTA (2 or 5 mM) at 37ºC or room temperature, followed by SDS – PAGE. The size and quantity of toxin in 171 
the soluble fraction was unaffected by incubation with the chelator under different conditions (data not shown). 172 
To test the possibility that the toxin interacted with EGTA and that this affected its toxicity, Cry41Aa was 173 
incubated with EGTA, dialysed and tested on cells. Its toxicity was fully retained after dialysis (data not shown). 174 
A shift towards more acidic pH was observed in culture medium (from 7.4 to 6.8) upon cell supplementation 175 
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with 2 mM EGTA, most likely due to protons being displaced by metal cations in the chelation reaction (21). 176 
We therefore investigated the toxicity of Cry41Aa in complete DMEM at lower pH values in the absence of 177 
EGTA. Toxin activity was unaffected at pH 6.84 (data not shown). 178 
3.3. Investigation of cations involved in toxicity 179 
Next, cells were additionally supplemented with CaCl2 or MgCl2 to see if toxicity could be restored despite the 180 
chelator’s presence. Ca2+, but not Mg2+, reinstated cytotoxicity of Cry41Aa in EGTA and EDTA pre-treated 181 
cells (Fig. 2). The Ca2+ salt reversed the chelator effect whether it was added 30 min before or after the toxin 182 
(data not shown). To confirm these results and further investigate any difference between Ca2+ and other cations, 183 
other chelators were tested at concentrations between 0 and 5 mM (Fig. 3). BAPTA is a derivative of EGTA, 184 
designed to be more selective for Ca2+ over Mg2+ than EGTA; however, it forms lower affinity Ca2+-chelates 185 
than EGTA (6.71 versus 7.18 at pH 7.4 (22)). DTPA is a membrane impermeable chelator often used in Zn2+ 186 
depletion studies. Only Zn2+ and, to a lesser extent, Cu2+, but not Ca2+ or Mg2+, were able to counteract the 187 
cytotoxic effect of DTPA in breast cancer cell lines after 48-hour exposure (23); however, DTPA has the 188 
capacity to bind other ions (24). Histidine is a ligand of a few metallic ions including Cu2+, Ni2+ and Zn2+ (25) 189 
but has negligible affinity for Ca2+. For this reason, it has been used alongside EGTA to test the involvement of 190 
Ca2+ in permeability of lymphocyte membranes (26, 27). In Fig. 3, BAPTA showed comparable results to those 191 
with EGTA, with the latter being slightly more efficient at cell protection against Cry41Aa. A higher 192 
concentration of DTPA was required to achieve this effect, while histidine had no significant impact, even at 193 
higher (up to 10 mM) concentrations (data not shown). 194 
These findings, pointing to a pivotal role of extracellular Ca2+ in Cry41Aa toxicity, were challenged in the next 195 
experiment conducted in Ca2+-free medium. Titration of EGTA was performed in Ca2+-free DMEM with and 196 
without FCS, as well as in complete DMEM (Fig. 4). Cells in DMEM devoid of extracellular Ca2+ resisted 197 
Cry41Aa at much lower EGTA concentration, compared to complete DMEM. When Ca2+-free DMEM was 198 
lacking FCS, which accounts for an additional source of trace metal cations, cells resisted Cry41Aa at even 199 
lower chelator dose. More importantly, in the absence of EGTA, toxin retained its activity in Ca2+-free DMEM 200 
without FCS, suggesting that EGTA bound other extracellular metal ions or ions (including Ca2+) present in 201 
cellular membranes. Chelating properties of EGTA can be calculated for Ca2+ and Mg2+ at any given pH with 202 
the Maxchelator program (http://maxchelator.stanford.edu). In a buffer containing 1.8 mM Ca2+ and 0.8 mM 203 
Mg2+ (levels in DMEM, Table 1) and 2 mM EGTA, 90.8% of the chelator is predicted to be bound at pH 7.4 204 
(37ºC, 0.165 N ionic strength), leaving a portion available to other reactions. The role of other metal ions was 205 
examined in their ability to counteract the EGTA effect. Fig. 5 shows that Ca2+, Mn2+ and Zn2+ supplementation 206 
most strongly reinstated Cry41Aa toxicity. Considering that Ca2+ counteracted the EGTA effect, we investigated 207 
whether increasing extracellular Ca2+ levels would increase Cry41Aa toxicity, like for example in the case of 208 
Cry1C in Sf9 cells (10). However, adding extra Ca2+ did not increase Cry41Aa toxicity in complete DMEM 209 
(data not shown). Next, the effect of Ca2+ and other metal ions was assessed in Ca2+-free medium and low toxin 210 
dose to better visualise viability changes (Fig. 6). In the absence of extracellular Ca2+, low quantities of Mn2+ 211 
and Zn2+ enhanced Cry41Aa toxicity, as did Ca2+. When similar experiments were conducted in the presence of 212 
normal Ca2+ concentrations (in complete or Advanced DMEM), addition of low levels of Zn2+ or Mn2+, but not 213 
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Ca2+, also increased Cry41Aa toxicity (data not shown). These findings suggest that cations other than Ca2+ can 214 
also positively affect toxicity. 215 
We next investigated what would happen to Cry41Aa toxicity in a basic buffer devoid of most metal cations, 216 
looking at toxin activity in DPBS in the presence of different BAPTA concentrations (Fig. 7). Much less 217 
BAPTA was required to abolish Cry41Aa toxicity in DPBS compared to Advanced DMEM. Also, in the 218 
absence of the chelator, like previously observed in Ca2+-free DMEM, the toxin was still able to cause swelling 219 
and to decrease cell viability, which suggests that cations bound to the membrane, rather than those in the 220 
medium, play a role in Cry41Aa toxicity. 221 
In cation supplementation experiments, addition of extra salts will change the equilibria of existing EGTA 222 
chelates. For instance, the addition of a large amount of Zn2+ could displace another metal cation from EGTA 223 
chelate, making it available to the cells and facilitate toxicity. Also, such high concentrations of trace metal ions 224 
like 2 mM Zn2+ or Cu2+ do not occur in physiological media and have adverse physiological effects on cells (28, 225 
29). A method was developed to avoid the problem of the unknown stoichiometry of each metal ion after 226 
supplementation in the presence of EGTA. An experiment was performed where culture medium after EGTA 227 
pre-treatment was removed before salt and toxin addition in DPBS (Fig. 8), following the observation that 228 
replacing culture medium with DPBS after EGTA pre-treatment still rendered cells resistant to toxin (Fig. 8, 229 
first bar). The high viability observed in Cry41Aa-treated cells in DPBS after EGTA removal suggests that, 230 
together with removed medium, all the metal cations needed for Cry41Aa toxicity have also been extracted from 231 
membranes due to EGTA chelation. Results show that trace levels of Zn2+ or Mn2+ alone could distinctly 232 
reinstate Cry41Aa toxicity. Elevated levels of Ca2+ (1 mM), but less than those present in DMEM formulation, 233 
not only restored but significantly enhanced toxicity of Cry41Aa, compared to toxin-treated cells where water 234 
instead of EGTA was used for transient treatment. 235 
3.4. Investigation of EGTA effect 236 
EGTA was the most efficient chelator tested here at cell protection (Fig. 3), therefore in subsequent experiments 237 
we focused on EGTA. To elucidate whether EGTA acts pre- or post-membrane damage, membrane 238 
permeability was assessed using the CellTox Green cytotoxic cell assay. In cells exposed to EGTA and 239 
Cry41Aa the membrane stayed impermeable to the small cytotoxic marker (<1 kDa) for 6 hours (Fig. 9). For 240 
confirmation and more information on the permeabilization process, whole-cell patch-clamp 241 
electrophysiological experiments were performed on single HepG2 cells. This sensitive method measures in real 242 
time the total ionic currents crossing the cellular membrane as a result of individual ion channel activity in the 243 
entire cell probed by the patch-clamp pipette. Cry41Aa induced large currents in HepG2 cells after 20 min 244 
exposure to the toxin, compared to the very small currents recorded at time 0, when the toxin treatment was 245 
initiated. Such response to the toxin was similar to that of the permeabilizing agent digitonin at 13 µg/ml (data 246 
not shown). However, Cry41Aa was not able to induce these large currents in the presence of EGTA after 20 247 
minutes of toxin treatment (Fig 10), or indeed after 5,10,15 or 30 mins of toxin exposure (data not shown). At 248 
20 min, the mean conductance levels were 12.5 and 266.9 nS for cells treated with Cry41Aa in the presence and 249 
absence of EGTA, respectively. Also, Cry41Aa had no effect on HeLa or CHOK1 cells (the whole cell currents, 250 
in the absence of EGTA, were similar to those observed in HepG2 cells without toxin – data not shown). 251 
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Furthermore, another experiment was performed to test for competition between Cry41Aa and EGTA and find 252 
out if toxicity could be reversed by late chelator administration (Fig. 11). EGTA was much less able to protect 253 
the cells when added more than a few minutes after the toxin, which confirms that it exerts its effect at an early 254 
stage in the cytotoxic process. 255 
For more clarification as to whether the chelator impedes toxin binding or the other steps in the mode of action, 256 
cell viability was assessed after transient EGTA and Cry41Aa treatment (Fig. 12). A cell washing step after 20-257 
minute incubation ensured that all non-bound toxin molecules and EGTA were removed. As shown in Fig. 12, 258 
high viability in cells transiently treated with Cry41Aa and EGTA indicates that the chelator prevented toxin 259 
interaction with the membrane within 20 minutes – a time that was sufficient to initiate cytotoxic effects in the 260 
chelator’s absence. Additional presence of Ca2+ throughout the 20-minute period promoted efficient toxicity of 261 
Cry41Aa. These results are consistent with a mechanism in which EGTA blocks the toxin from binding to the 262 
cell membrane. 263 
Whole-cell patch-clamp experiments indicated that Cry41Aa triggers substantial whole-cell currents either by 264 
altering the endogenous channels in HepG2 cell membranes, or by creating channels de novo, or both. To 265 
determine the ability of toxin insertion into lipid membranes, channel activity was monitored in planar lipid 266 
bilayers. Fig. 14 (left panel), which shows single channel currents in a typical experiment (out of three similar 267 
and independent experiments), is the first direct demonstration that Cry41Aa is a pore-forming toxin. Fig. 13 268 
shows the current-voltage relationships derived from unitary channel current measurements in recordings 269 
performed at different voltages. Calculated conductances of the most common conducting states or substates of 270 
the channels formed by the toxin ranged from 75 to 220 pS and there was no rectification (Fig.13). As shown on 271 
the left panel of Fig. 14, one or more channels remained always open at both positive and negative voltages, 272 
with only very few short closures, indicative of the channels' opening probability being close to 1. Experiments 273 
conducted in 450 mM:150 mM KCl conditions (data not shown) indicated that the channels were slightly 274 
cation-selective, with a mean reversal potential from three independent experiments of -10.97 (± 1.00) mV and a 275 
PK+/PCl- of 2.48 (± 0.23). Furthermore, EGTA (2 mM) not only did not prevent pore formation by the toxin in 276 
planar lipid bilayers, but may even have increased the overall channel currents, as shown on the right panel of 277 
Fig. 14, in which the total current at any voltage is larger, suggesting the presence of additional single channels 278 
with a similar opening probability close to 1. Further comparative analysis (with and without EGTA) of the 279 
channels' activity was made difficult by the fact that there were several channels simultaneously active in the 280 
current recordings and that only a few, very short unitary current jumps were observed in each of them. In any 281 
case, this data is consistent with EGTA's hypothesised role of binding divalent cations present in biological 282 
membranes. 283 
4. Discussion 284 
Bt Cry toxins have been widely used as biopesticides for over 50 years with no harmful effects on humans (30). 285 
Parasporins represent a relatively new group of Bt toxins that can specifically kill certain human tumour cells in 286 
vitro (3). Some parasporins, like Cry41Aa, are closely related in structure to insecticidal Cry toxins; however, at 287 
the moment parasporin activity cannot be predicted based on a toxin’s sequence. The preferential and narrow 288 
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cytocidal activity of Cry41Aa may have potential for anticancer drug design in the future. Our previous research 289 
suggested that Cry41Aa kills hepatic liver cancer cells via a pore-forming mechanism (8). In this study, we 290 
directly demonstrated its pore-forming nature and investigated the protective role of chelators such as EGTA 291 
that renders HepG2 cells resistant to Cry41Aa. Our results indicate that EGTA prevented the toxin’s interaction 292 
with the cellular membrane, and the subsequent steps of membrane damage and p38 phosphorylation, by 293 
chelating metal cations, like Ca2+, Mn2+ and Zn2+, present in plasma membrane components and important for 294 
Cry41Aa binding. 295 
The chelator action appears to result from metal ion chelation rather than indirect effects, such as interaction 296 
with the toxin. Analysis of membrane permeability revealed that the chelator protected cells from membrane 297 
damage. This concurs with the fact that EGTA prevented phosphorylation of p38 MAP kinase, a signalling 298 
pathway often triggered by pore formation (20). Ratner et al. also demonstrated that EGTA abolished p38 299 
activation in pneumolysin-treated A549 epithelial cells (31). Moreover, a number of investigators demonstrated 300 
that non-lytic mutants of some PFTs like E. coli hemolysin A or S. aureus α-toxin failed to activate p38 (32, 33). 301 
EGTA prevented stable interaction between the toxin and the cell membrane, as culturing cells in fresh medium 302 
after transient EGTA and toxin treatment resulted in high viability. Further experiments revealed that the later 303 
EGTA was administered relative to toxin treatment, the more ineffective it was in cell protection. When a 304 
chelator like EGTA is added to a solution, equilibrium is reached relatively quickly within µs to ms, depending 305 
on the rate constants of the equilibrium reaction and the ionic strength of the solution. This indicates that the 306 
initial few minutes are required for toxin interaction with the membrane. This would be the diffusion time it 307 
takes for the toxin to reach and bind membranes but could also include oligomerisation of the toxin. In HepG2 308 
cells exposed to PS2 (Cry46Aa1), membrane associated oligomers were detected after 10 minutes on a ligand 309 
blot membrane with the signal reaching its highest intensity after 60 minutes (34). It seems that as soon as 310 
EGTA is added, it prevents further toxin action, but it cannot undo the damage already created. This is 311 
consistent with the results of a study by Kirouac et al. who showed that EDTA (and, to some extent, EGTA) 312 
inhibited the rate of pore formation by Cry1Aa but did not alter the pores that were already formed (9). 313 
Perhaps the most surprising observation in the present study was that EGTA exerted its protective effect by 314 
chelating cations bound to plasma membrane components rather than those present in the extracellular medium. 315 
This was based on findings that Cry41Aa was active on cells in DPBS or Ca2+-free DMEM without FCS, in the 316 
absence of chelators, but minute amounts of EGTA or BAPTA abolished this activity. Both chelators show 317 
negligible affinities for K+ or Na+, the only two metal ions present in DPBS formulation; therefore, the removal 318 
of extracellular cations cannot explain the observed cell protection effect of the chelators. The most plausible 319 
explanation is that EGTA’s affinity for the cations in question was stronger than the protein-cation affinity in 320 
HepG2 cell membranes, pulling them out of their binding partners. Chelator titration curves support the idea of 321 
Ca2+ being the cation of major importance in Cry41Aa mode of action. BAPTA which forms lower affinity 322 
Ca2+-complexes compared to EGTA was somewhat less effective in preventing cell death than EGTA. The 323 
ability of high concentrations of DTPA to preserve cell viability was most likely caused by metal chelation other 324 
than Zn2+. Whereas 1.2 mM of DTPA was optimal to chelate Zn2+ in osteoblastic MC3T3-E1 cells (35), much 325 
smaller concentrations (0.1 mM) were successfully used to do so in MCF-7 and MDA-MB468 breast cancer 326 
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cells (23). In our experiments, even 2 mM DTPA was not able to fully protect the cells from the toxin’s damage. 327 
Moreover, histidine, a poor Ca2+ chelator, did not inhibit Cry41Aa toxicity.  328 
Significant increase in the whole-cell conductance, to a few hundred nS, was observed in HepG2 cells exposed 329 
to Cry41Aa. The most plausible explanation is de novo channel formation rather than activation of endogenous 330 
channels, as HepG2 cell channel conductances reported under similar experimental conditions are relatively 331 
low. Malhi et al. found that the whole-cell currents from HepG2 cells in the absence of ATP (a K+ channel 332 
inhibitor) were low and ATP-sensitive K+ channels in these cells required drug stimulation for full channel 333 
activation, indicating decreased basal activity of these channels (36). Characterization of single channels in 334 
HepG2 cells revealed the presence of calcium- and voltage-dependent channels with conductance values of 18.9 335 
in KCl and 19.8 pS in NaCl solutions in the inside-out configuration, and 22.2 in KCl and 19.7 pS in NaCl 336 
solutions in the cell-attached configuration (37). Low amplitude single-channel currents were also recorded in 337 
mammalian hepatocytes (38-41). The endogenous HepG2 channel conductances are almost one order of 338 
magnitude lower than what was measured in this study using planar lipid bilayers, which suggests that the 339 
channel activity underlying the large whole-cell currents observed in the present study most likely correspond to 340 
larger conductances from pores made by the toxin itself. However, contribution of endogenous channel activity 341 
cannot be completely ruled out. Indeed, it has been demonstrated before that the initial response of Sf9 insect 342 
cells to Cry1C exposure involved a calcium influx via voltage-dependent Ca2+ channels (42). Here, planar lipid 343 
bilayer experiments provided evidence for the formation of stable, slightly cationic channels with multiple 344 
conductance levels, suggesting either different substates of a single channel population or a few separate 345 
channel populations, or both. For comparison, conductance values for other Cry toxins in planar lipid bilayers 346 
were, when determined under symmetrical 150mM KCl conditions: 461 pS for Cry1Ac, 350 pS for Cry1B, 90 347 
pS for Cry1C, 450 pS for Cry1Aa (43), 125 pS or less for Cry5B (44), and 11, 16 and 21 pS for a PS1 homolog 348 
– Cry31Aa2 (45). The lack of effect of EGTA on Cry41Aa activity in planar lipid bilayers most likely resulted 349 
from the use of a simple experimental channel reconstitution system made of lipid bilayers that are devoid of 350 
cellular membrane proteins and thus do not allow for cation binding to the artificial membranes. On the other 351 
hand, the EGTA preventive action observed in whole-cell experiments implies that Cry41Aa mode of action in 352 
biological membranes of susceptible cells is fully facilitated with the help of specific binding molecules (so-353 
called receptors), whose integrity or function, or both, are associated with metal cations. This is also supported 354 
by the resistance of HeLa or CHOK1 cells to the toxin at the electrophysiological level, which most likely lack 355 
these receptors. 356 
Table 1 presents formation constants for some of metal-EGTA complexes. However, EGTA-metal equilibria are 357 
calculated with only one type of cation present and in a situation when EGTA is fully dissociated at alkaline pH 358 
(at physiological pH complexes will be less stable). Since EGTA forms complexes with many metallic cations, 359 
it is difficult to predict the levels of the un-chelated free metal ions available to cells after EGTA treatment in 360 
culture medium. What is known is that both the abundance of metal ions (if they are major constituents in 361 
DMEM like Ca2+ or Mg2+ or minor like Zn2+ or Mn2+) and their ability to form stable complexes with the 362 
chelator at experimental pH, will highly influence the actual equilibria (21). Considering that the biological 363 
levels of Zn2+ and Mn2+ are in the µM and nM range respectively and that EGTA-metal stability constants are 364 
higher for Mn2+, Zn2+, etc. than for Ca2+ (46), the addition of large quantities of Zn2+ or Mn2+ in some of our 365 
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experiments most likely created variations in the equilibrium concentrations of all the strongly chelated as well 366 
as un-chelated ions releasing other ions that formed less stable complexes with EGTA. For example, added Zn2+ 367 
could displace Ca2+, which when released could facilitate Cry41Aa action. However, when EGTA was present 368 
in the cell medium throughout the experiments, results were comparable to those of experiments where ion 369 
supplementation was done in the chelator’s absence or after its removal, as summarized in the cartoon shown in 370 
Fig. 15. Our findings highlight the role of Mn2+, Zn2+ and Ca2+ in Cry41Aa toxicity.  371 
Ions play important roles in cellular metabolism and extracellular processes, yet there is no unified view on the 372 
role of divalent cations in Cry toxin mode of action. PS1 (Cry31Aa1) seems to use changes in the cytosolic Ca2+ 373 
concentration as a messenger system. This toxin induced influx of extracellular Ca2+ and apoptosis, by 374 
activating trimeric G-protein signalling, as suramin, which inhibits this pathway, suppressed both the Ca2+ influx 375 
and cytotoxicity of PS1-treated HeLa cells (6). Fortier et al. also highlighted the importance of divalent cations, 376 
ionic strength and pH in the Cry toxin mechanism of action (12). These authors postulated that binding and pore 377 
formation could be influenced by electrostatic interactions between the toxin molecules and the membrane. 378 
Experiments using membrane potential measurements and osmotic swelling assays with insect BBMV showed 379 
that at higher pH values, both ionic strength and divalent cations screen negative charge at both the toxin and 380 
membrane surfaces increasing their interaction (12). Finally, Kirouac et al. demonstrated that EDTA inhibited 381 
pore formation by Cry1Aa, Cry1Ac, and Cry1Ea in isolated BBMV, a system devoid of cellular content and 382 
metabolism, suggesting the role of metal ions in processes other than signalling pathways (9). In contrast to PS1, 383 
extracellular cations are not mandatory for Cry41Aa activity. Our results indicate that EGTA acted at an early 384 
stage, preventing an effective toxin interaction with the membrane by means of chelating membrane bound ions. 385 
A large number of proteins are found that coordinate factors - often metal ions - to facilitate specific functions 386 
and help stabilize protein structures (47). Changes in the conformation or functionality of a membrane 387 
receptor(s) could account for the results presented in this study and was proposed before to explain the EDTA 388 
effect on Cry1 toxins (9). Upon the addition of EDTA, a large conformational transition occurs in a cadherin 389 
structure, from a rod-like to globular shape (48). It has been further shown by Candas et al. that Ca2+ removal 390 
mediates cleavage of the ectodomain of cadherin BT-R1 – a target receptor for Cry1A toxin - leading to its 391 
destabilisation and proteolytic cleavage (49). Ca2+, Zn2+ and Mn2+ most prominently reinstated Cry41Aa toxicity 392 
and, crucially, after transient EGTA treatment. Our observations may suggest the presence of multiple receptors. 393 
Interestingly Zn2+-dependent metalloproteases (aminopeptidase N APN), Zn2+-binding proteins (alkaline 394 
phosphatase ALP) and Ca2+-stabilised proteins (cadherin-like proteins) have previously been identified as 395 
functional Cry toxin receptors in insects (50). The possibility that metal cations facilitate Cry41Aa toxicity in a 396 
cooperative fashion appears quite plausible in light of the present work. Cry41Aa may require more than one 397 
receptor to be active, each coordinating a different metal. Such a multiple receptor requirement has been 398 
proposed in the sequential binding model in which both APN and cadherin receptors have been suggested for 399 
Cry1Ab toxicity towards M. sexta (51). Another possibility is that the identified metal ions show functional 400 
redundancy in the main receptor (following EGTA facilitated metal release, a different metal can be selected for 401 
to maintain protein’s structure and/or function), as proteins often adopt flexible metal binding sites, allowing 402 
non-specific interactions with many divalent metal cations depending on their bioavailability (52). 403 
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8. Figure and table legend 546 
 547 
Figure 1 Effect of EGTA on Cry41Aa toxicity in HepG2 cells. 548 
Analysis of viability (A) and p38 phosphorylation (B) was assessed in chelator pre-treated HepG2 cells exposed to Cry41Aa. 549 
A) Cells were seeded in complete DMEM. The next day, the cells were preincubated with 5 mM of either EGTA or EDTA 550 
or mock for 30 min followed by the addition of Cry41Aa (12 µg/ml). The readings were taken 5 h after toxin addition using 551 
the CellTiter-Blue assay. B) HepG2 cells were pre-treated with 2 mM EGTA or water for 10 min. Next, sodium arsenite (0.5 552 
mM), Cry41Aa (15 µg/ml) or buffer were added. Cells were lysed in NP-40 15 min after toxin treatment. 10 µg of proteins 553 
were loaded in each lane and after SDS-PAGE proteins were subject to western blot analysis for the presence of 554 
phosphorylated p38 (p p38) and CD59 (loading control). 555 
 556 
Figure 2 Effect of supplemental Ca2+ and Mg2+ ions on the chelator induced suppression of Cry41Aa activity. 557 
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Cells were seeded in complete DMEM. The next day cells were preincubated with 5mM of either EGTA or EDTA or mock 558 
for 30 min followed by the addition of Cry41Aa (12 µg/ml). 5 mM of CaCl2 or MgCl2 was added to the appropriate wells 10 559 
min before the toxin. The readings were taken 5 h after toxin addition using the CellTiter-Blue assay. 560 
 561 
Figure 3 The effect of different metal chelators on Cry41Aa toxicity.  562 
Cells were seeded in Advanced DMEM. The next day, cells were incubated for 30 min with different concentrations of 563 
EGTA, BAPTA, DTPA or histidine before Cry41Aa (10 µg/ml) was added. Viability was measured 5 h after toxin addition 564 
using the CellTiter-Blue assay.  565 
 566 
Figure 4 EGTA titration in DMEM with different Ca2+ levels and its effect on Cry41Aa activity.  567 
Cells were seeded in complete DMEM and Ca2+-free DMEM with or without FCS. Cells in complete DMEM were seeded 568 
24 h before the experiment and cells in Ca2+-free DMEM on the same day. Cells were treated with different concentrations 569 
of EGTA and 30 min later with Cry41Aa (12 µg/ml). CellTiter-Blue cell viability assay was used to measure viability 5 h 570 
later. 571 
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 572 
Figure 5 Effect of different salts on cells exposed to EGTA and Cry41Aa in Ca2+-free DMEM. 573 
Cells were seeded in Ca2+-free medium followed by treatment with 2 mM EGTA or water. 10 min later different 574 
concentrations of salts were added followed by either Cry41Aa (10 µg/ml) or buffer treatment. Viability was measured 5 h 575 
later using the CellTiter-Blue assay. Addition of >1 mM of ZnSO4 and CuCl2 to cells resulted in decreased viability (~35% 576 
and 15% viability drop in cells treated with 2 mM CuCl2 and ZnSO4 respectively) therefore normalisation was done for the 577 
effect of all salts. Normalized data was then plotted as a percentage of the EGTA- and Cry41Aa-treated cells.  578 
 579 
Figure 6 The effect of metal salts on residual Cry41Aa toxicity in Ca2+-free DMEM. 580 
Cells were seeded in Ca2+-free DMEM. After 30 min cells were supplemented with various concentrations of metal salts: 581 
CaCl2, MnSO4, ZnSO4, FeSO4, FeCl3, CuCl2 or MgCl2, followed by either Cry41Aa (5 µg/ml) or buffer treatment. Viability 582 
was measured 5 h after toxin treatment using the CellTiter-Blue assay. Bars with asterisks are significantly different from 583 
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control cells exposed to Cry41Aa (5 µg/ml) in Ca2+-free DMEM without supplementation (* p< 0.005, Post-Hoc comparison 584 
with Bonferroni correction).  585 
 586 
Figure 7 Titration of BAPTA in Advanced DMEM and DPBS and its effect on Cry41Aa activity.  587 
BAPTA in DPBS treatment: cells were seeded in Advanced DMEM. The next day cells were washed once with DPBS and 588 
fresh DPBS was placed in the wells. Different concentrations of BAPTA were added and 30 min later Cry41Aa was 589 
administered (10 µg/ml). Viability was measured 3 h later using the CellTiter-Blue assay. BAPTA in Advanced DMEM 590 
treatment: cells were seeded in Advanced DMEM. The next day cells were incubated with different concentrations of 591 
BAPTA. After 30 min Cry41Aa (10 µg/ml) was added and viability was measured 5 h later using CellTiter-Blue assay.  592 
 593 
Figure 8 Effect of different salts on Cry41Aa-treated cells in DPBS after EGTA removal. 594 
Cells were seeded in complete DMEM. The next day cells were treated with 2 mM EGTA or water for 10 min. After that the 595 
medium was removed from wells and DPBS was added. Five min later different concentrations of salts or water were added, 596 
followed by either Cry41Aa (10 µg/ml) or buffer treatment. Viability was measured 4 h later using the CellTiter-Blue assay. 597 
Data was plotted as a percentage of the cells treated +/-chelator, +/-salt and with buffer. Bars with asterisks show significant 598 
differences from control (cells exposed to Cry41Aa at 10 µg/ml in DPBS without salt supplementation after transient 599 
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treatment with 2 mM EGTA - first bar), * p< 0.001, Post-Hoc comparison with Bonferroni correction. Cell incubation with 600 
0.05 mM CuCl2 in DPBS resulted in decreased cell viability (20%) after 4 h, masked here by data normalisation. 601 
 602 
Figure 9 Effect of EGTA on HepG2 cell membrane permeability.  603 
HepG2 cells were seeded in complete DMEM in the presence of CellTox Green dye in a black 96-well plate. The next day, 604 
cells were pre-treated with 5 mM EGTA or mock 30 min before treatment with Cry41Aa (12 µg/ml) or buffer. Membrane 605 
permeability was measured using the CellTox Green cytotoxicity assay at different times after toxin addition. 606 
 607 
Figure 10 Whole-cell patch-clamp recordings from cells exposed to Cry41Aa in the presence or absence of EGTA. 608 
Whole-cell patch-clamp recordings from a single cell were reported at 0 and 20 min after the addition of Cry41Aa (12 609 
µg/ml) to the bath in the presence or absence of 2 mM EGTA. Currents were induced by a 1 second set of depolarizing 610 
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potentials from -20 to 140 mV from a holding potential of -20 mV. The lines show the mean currents from three 611 
representative experiments from three different patched cells. Error bars indicate the standard error of the mean. 612 
 613 
Figure 11 Administration time-dependent effect of EGTA. 614 
Cells were seeded in complete DMEM. The next day cells were treated with 2 mM EGTA at different time points: before, at 615 
the same time as, or after Cry41Aa (12 µg/ml). Viability was measured 6h after toxin addition using the CellTiter-Blue 616 
assay. Control cells were treated with water and exposed to Cry41Aa (12 µg/ml) for 6 h.  617 
 618 
Figure 12 Effect of transient treatment with Cry41Aa and EGTA on cell viability. 619 
Cells were seeded in complete DMEM. The next day cells were preincubated with either 5 mM EGTA or 5 mM EGTA and 620 
5 mM CaCl2 or mock. After 30 min Cry41Aa (12 µg/ml) or buffer was added, and cells were incubated for further 20 min. 621 
Then all cells were washed twice with DPBS and re-suspended in complete DMEM. Viability was assessed using the 622 
CellTiter-Blue assay 24 h after toxin addition. Results are represented as % viability relative to cells washed after treatment 623 
with EGTA and buffer. 624 
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 625 
Figure 13 Single-channel current - voltage relationship recorded in planar lipid bilayers in the presence of Cry41Aa. 626 
Current-voltage relationships (I-V curves) of single-channel activity of Cry41Aa (8 µg/ml) in a typical PLB experiment, 627 
representative of three independent experiments, performed under identical symmetrical (150 mM:150 mM KCl cis/trans) 628 
conditions. The data points could be fitted by three linear regressions (shown by ●, ■, and ▲ symbols) passing through the 629 
origin of the I and V axes. The calculated slopes of these regression lines represent the conductances of the three most 630 
common conducting states or substates of the channels formed by the toxin.  In this particular experiment, they were equal to 631 
79 pS (■), 122 pS (●) and 196 pS (▲). 632 
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 633 
Figure 14 Cry41Aa induced channel formation in planar lipid bilayers in the presence or absence of EGTA. 634 
Representative single-channel current traces of Cry41Aa (8 µg/ml) were recorded in planar lipid bilayer at various voltages 635 
in the presence or absence of 2 mM EGTA under symmetrical (150 mM:150 mM KCl) conditions. Traces were filtered at 1 636 
kHz. 637 
 638 
Ions DMEM Ca2+-free 
DMEM 
Advanced 
DMEM 
DPBS Patch-
clamp 
buffer 
PLB 
buffer 
EGTA-metal 
absolute stability 
constant 
Ca2+ 1.8 - 1.8 - 1.1 1 11 
Mg2+ 0.8 0.8 0.8 - 1.1  5.2 
Fe3+ 2.4E-4 2.4E-4 2.4E-4 - - - 20.5 
Fe2+ - - - - - - 11.9 
Mn2+ - - 3.9E-7 - - - 12.3 
Zn2+ - - - - - - 14.5 
Cu2+ - - 7.8E-6 - - - 17.8 
 639 
Table 1 Levels of main divalent metal ions in cell media used and EGTA-metal stability constants.  640 
Amounts (mM) of metal cations present in cell culture media were obtained from the supplier’s website 641 
(www.thermofisher.com/uk/en/home.html). All culture media had pH 7.4. The table does not take into account cations 642 
present in FCS. EGTA-metal stability constants were taken from Cheng, et al. (42). 643 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
24 
 
 644 
Figure 15 Experimental evidence for the role of Zn2+, Ca2+ and Mn2+ in Cry41Aa toxicity. 645 
Graphic representation of experimental design and results involving salt supplementation. (A) Zn2+, Ca2+ and Mn2+ enhanced 646 
Cry41Aa toxicity in Ca2+-free medium. (B) Restored toxin activity after EGTA treatment in complete medium. (C) 647 
Facilitated Cry41Aa toxicity in DPBS after transient EGTA treatment.  648 
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Highlights: 
• EGTA, EDTA, BAPTA and DTPA chelators protect HepG2 cells from Cry41Aa cytotoxicity. 
• EGTA removes membrane bound cations preventing toxin binding and membrane damage. 
• Cry41Aa induces pore formation in planar lipid bilayers, also in EGTA’s presence. 
• Ca
2+
, Mn
2+
 and Zn
2+
 reinstated cytotoxicity in salt supplementation assays.  
• Toxin’s action is dependent on interaction with metal cation-dependent receptor(s). 
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